Rosuvastatin protects against oxidized low-density lipoprotein-induced endothelial cell injury of atherosclerosis in vitro

Atherosclerosis-induced cardiovascular diseases (CVDs) are accompanied by substantial morbidity and mortality. The loss and injury of endothelial cells is the primary cause of atherosclerosis. Rosuvastatin is an alternative agent used to reduce the risk of cardiovascular disease. Subsequently, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Jianan, Xu, Huali, Yu, Xiaofeng, Xu, Guoliang, Cao, Hongyan, Lin, Guangzhu, Sui, Dayun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297788/
https://www.ncbi.nlm.nih.gov/pubmed/30483737
http://dx.doi.org/10.3892/mmr.2018.9666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297788/
https://www.ncbi.nlm.nih.gov/pubmed/30483737
http://dx.doi.org/10.3892/mmr.2018.9666

Ejemplares similares